BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240109
DTEND;VALUE=DATE:20240112
DTSTAMP:20260516T004430
CREATED:20231026T085211Z
LAST-MODIFIED:20231026T085354Z
UID:38024-1704758400-1705017599@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes and Injectable Drug Devices Europe
DESCRIPTION:SAE Media Group’s 16th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January 2024 to unite leaders from the industry and bring you the latest advances in the combination product drug delivery space. \n \nYear on year\, the field of injectable drug delivery has witnessed remarkable progress\, marked by advancements in device technology\, including smart devices and those designed for large volume drug administration. There has been a shift towards enhancing the patient experience through innovative device design. Moreover\, the industry is now moving towards a circular approach for environmental sustainability\, incorporating it into device manufacturing and design\, as well as device usage. The upcoming conference aims to tackle pressing industry challenges by exploring them through real-world case studies and valuable insights while also considering opportunities for the future. \nAs part of SAE’s leading Injectable Drug Delivery Series\, the 3-day event will comprise of a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below addressing the industry’s hottest topics: \n\nDevice Innovations for Large Volume and Highly Viscous Drug Delivery\nSustainability by Design and Material Selection\nPrimary Packaging Development\nDigital Integration for Connected Devices\n\nThis event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in January 2024! \nBenefits of attending:  \n\nEngage with pharma\, biotech and device developers on the latest trends within the pre-filled syringe and injectable device market\nHear about new technological advances in the delivery of large volume drugs and novel drug products\nUnderstand the latest regulatory requirements from experts surrounding medical devices and digital health\nGain insight into how big pharma is incorporating sustainable approaches into drug device design\nDelve into the growing potential of digital health to improve patient experience and treatment\n\nExplore key considerations for material components for the development of primary packaging \nTo know more visit: www.pre-filled-syringes.com/PharmaJournalist-WL
URL:http://www.pharmajournalist.com/event/pre-filled-syringes-and-injectable-drug-devices-europe-2024/
LOCATION:LEONARDO ROYAL HOTEL LONDON TOWER BRIDGE\, 45 Prescot Street\, London\, E1 8GP\, United Kingdom
ORGANIZER;CN="SAE Media Group":MAILTO:events@saemediagroup.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240123
DTEND;VALUE=DATE:20240126
DTSTAMP:20260516T004430
CREATED:20230927T095451Z
LAST-MODIFIED:20230929T103625Z
UID:37864-1705968000-1706227199@www.pharmajournalist.com
SUMMARY:Gene Therapy Regulatory Affairs Summit
DESCRIPTION:With 2023 welcoming newly FDA-approved gene therapies from BioMarin\, Krystal Biotech and Sarepta Therapeutics\, many more treatments are hot on their heels for approval\, investment is pouring into developing gene therapies and the role of regulatory affairs has never been more important. \nAs the first ever regulatory affairs forum wholly dedicated to gene therapy\, this meeting uniquely unites regulatory bodies and the leading regulatory personnel across big pharma and innovative biotech to discuss the hottest topics\, identify industry bottlenecks and offer actionable insights. \nJoin 80+ industry leaders from 4D Molecular Therapeutics\, Advanced Cell & Gene Therapy\, Adverum Biotechnologies\, Astrazeneca\, Bridge Bio\, Health Canada\, Omega Therapeutics\, Opus Genetics\, Regeneron Pharmaceuticals\, Sangamo Therapeutics\, Solid Biosciences\, Spark Therapeutics\, Ultragenyx Pharmaceutical\, and more… \nBy attending this summit\, you will get a chance to: \n\nUnderstand the nuanced differences and the route to harmonization in global regulation across the EMA\, MHRA\, FDA & Health Canada\nHone your regulatory intelligence\, understand how to use biomarkers as surrogate endpoints and perfect clinical trial strategy for regulatory success\nExplore the next steps for specific technologies beyond AAV and novel regulatory route\nHear from the regulators in the Health Canada and the FDA to have your queries clarified\n\nOvercome your CMC hurdles to prove the efficacy\, purity & comparability of your compound to avoid later setbacks in poor manufacturing preparation \nDon’t miss out on this unrivalled opportunity to inform your trial design\, perfect your CMC approach and supercharge your global submission strategy for regulatory success. \nDownload the full agenda here to see our full speaker faculty\, 3-day agenda and audience breakdown: https://ter.li/sgkcr9
URL:http://www.pharmajournalist.com/event/gene-therapy-regulatory-affairs-summit/
LOCATION:Boston Park Plaza\, 50 Park Plaza\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240123
DTEND;VALUE=DATE:20240126
DTSTAMP:20260516T004430
CREATED:20231006T112619Z
LAST-MODIFIED:20231006T112619Z
UID:37924-1705968000-1706227199@www.pharmajournalist.com
SUMMARY:3rd mRNA-Based Therapeutics Summit Europe
DESCRIPTION:250+ mRNA Specialists | 40+ World-Class Speakers | 2 Streams of Content \nThe 3rd mRNA-Based Therapeutics Summit Europe returns to Berlin this 23rd-25th January to unite European biopharma\, to hear from the likes of BioNTech\, CureVac\, Moderna\, Pfizer\, Ethris\, Sanofi\, and regulatory insights for the MHRA and EMA. \nDownload the full brochure here: https://ter.li/1329up \nThis is your opportunity to hear the hottest content of the mRNA world\, deep diving into two content tracks on Translational Development and CMC\, a pre-conference Focus Day on AI RNA Design & Delivery\, and three immersive pre-conference workshops. \nJoin in January to understand the roadmap towards clinical success and regulatory approval\, and deliver the promise of better mRNA medicines to patients faster. \nBook your place here: https://ter.li/qu2h8f
URL:http://www.pharmajournalist.com/event/3rd-mrna-based-therapeutics-summit-europe/
LOCATION:Mecure Hotel MOA Berin\, Stephanstraße 41\, Berlin\, 10559\, Germany
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240130
DTEND;VALUE=DATE:20240202
DTSTAMP:20260516T004430
CREATED:20231206T112751Z
LAST-MODIFIED:20231206T112751Z
UID:38270-1706572800-1706831999@www.pharmajournalist.com
SUMMARY:2nd Next Generation Ophthalmic Drug Delivery Summit
DESCRIPTION:The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers\, biochemists\, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration. \nJoin 23+ expert speakers from the likes of AbbVie\, Boehringer Ingelheim\, Bayer\, Genentech\, Janssen\, Novartis\, and Clearside Biomedical at the only industry-dedicated event focusing on overcoming key translational challenges of developing and implementing novel delivery technology as they progress their ophthalmic pipelines to the clinic. \nTo know more visit: https://ter.li/o3pq3n
URL:http://www.pharmajournalist.com/event/2nd-next-generation-ophthalmic-drug-delivery-summit/
LOCATION:The Marker San Francisco\, 501 Geary St\, San Francisco\, CA\, 94102\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240130
DTEND;VALUE=DATE:20240202
DTSTAMP:20260516T004430
CREATED:20240105T091432Z
LAST-MODIFIED:20240105T091432Z
UID:38450-1706572800-1706831999@www.pharmajournalist.com
SUMMARY:8th Microbiome Movement - Drug Development Summit Europe
DESCRIPTION:As Europe’s premiere microbiome conference tightly focused on the development of microbiome-based therapeutics\, this is your prime opportunity to expand your microbiome-based drug development capabilities and business potential as we aim to deliver clinical results and ensure therapeutic microbiome approval in Europe. \nNo matter what stage of development you’re focusing on\, this is your one-stop shop for microbiome-based drug development from early discovery to late-phase manufacturing! \nWhat’s New for 2024: \n\nHighlighting early-stage organisations and their novel technologies in our brand-new technology showcase where we welcome Centre for Genomic Regulation\, Recolony and Synflora to give quick fire presentations to showcase their work.\nDiscover our new enabling technologies track to learn more about the exciting artificial intelligence\, integrated -omics analysis and improved manufacturing capabilities among the other technologies that are accelerating microbiome-based drug development.\nStrengthen your regulatory understanding and enhance decision-making by uncovering global regulations to address updated SoHo frameworks\, explore considerations for engineered microbes and consolidate agencies interactions\n\nTo know more visit: https://ter.li/zi3xwf
URL:http://www.pharmajournalist.com/event/8th-microbiome-movement-drug-development-summit-europe/
LOCATION:Hotel Barceló Sants\, Pl. dels Països Catalans\, s/n\, 08014\, Barcelona\, 08014\, Spain
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR